TuHURA Biosciences, Inc. Common Stock
HURA •
Buy Open
Signal type
Buy
Status
Open
Open Price
$2.30
Stop Loss
$1.66
Performance
37.25%
Days Open
5
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 10, 2026
Open Price $2.30
Stop Loss $1.66
Timespan Day
Company Profile
Name TuHURA Biosciences, Inc. Common Stock
Ticker HURA
Market Cap $103.80M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $3.15
List Date Oct 18, 2024
Description
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
Website Open Company Website